| Citation: |
SONG Lin, LIN Hua, ZHENG Ruiqiang, JIANG Wei, LI Xianghui, SHAO Jun. Analysis in pathogenic bacteria distribution and risk factors of nosocomial infection in patients with extracorporeal membrane oxygenation[J]. Journal of Clinical Medicine in Practice, 2022, 26(15): 8-14. DOI: 10.7619/jcmp.20220979
|
To analyze the pathogenic bacteria distribution and risk factors of nosocomial infection in patients with extracorporeal membrane oxygenation (ECMO).
Clinical materials of 76 patients with ECMO were analyzed, and they were divided into infection group and non-infection group. The infection situation and its risk factors as well as the distribution of detected pathogenic bacteria and their drug resistance were analyzed, and the risk factors of nosocomial infection after ECMO were analyzed by receiver operating characteristic (ROC) curve.
The incidence of nosocomial infection in 76 patients was 53.95% (41/76), lower respiratory tract (76.12%) was the main infection site, and the detection rate of Gram-negative bacilli was the highest (85.07%). There were significant differences in age, mechanical ventilation time, ECMO assisted time, antibacterial drug use time, central venous catheterization time and catheter catheterization time between the two groups (P < 0.05 or P < 0.01). Logistic regression analysis showed that ECMO assisted time and mechanical ventilation time were the independent risk factors for nosocomial infection (P < 0.05). ROC curve analysis showed that the area under the curve (AUC) of ECMO assisted time to predict nosocomial infection after ECMO was 0.812, the best critical value was 128.04 h, the sensitivity was 68.3%, and the specificity was 85.7%; the AUC of mechanical ventilation time in predicting nosocomial infection after ECMO was 0.873, the best critical value was 64.48 h, the sensitivity was 97.6%, and the specificity was 68.6%.
The nosocomial infection rate after ECMO is high, the lower respiratory tract is the main infection site, and most of pathogenic bacteria are Gram-negative bacteria, the proportion of multidrug-resistant bacteria is high, and mechanical ventilation time and ECMO assisted time are the independent risk factors for nosocomial infection.
| [1] |
BRODIE D, SLUTSKY A S, COMBES A. Extracorporeal life support for adults with respiratory failure and related indications: a review[J]. JAMA, 2019, 322(6): 557-568. doi: 10.1001/jama.2019.9302
|
| [2] |
HILL J D, O'BRIEN T G, MURRAY J J, et al. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung[J]. N Engl J Med, 1972, 286(12): 629-634. doi: 10.1056/NEJM197203232861204
|
| [3] |
WANG D W, HU B, HU C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China[J]. JAMA, 2020, 323(11): 1061-1069. doi: 10.1001/jama.2020.1585
|
| [4] |
唐晓, 蒲琳, 张佳莹, 等. 体外膜肺氧合治疗危重症新型冠状病毒肺炎和新型甲型H1N1流感病毒性肺炎临床特征和预后比较[J]. 中华医学杂志, 2021, 101(8): 579-585.
|
| [5] |
ABRAMS D, COMBES A, BRODIE D. Extracorporeal membrane oxygenation in cardiopulmonary disease in adults[J]. J Am Coll Cardiol, 2014, 63(25 Pt A): 2769-2778.
|
| [6] |
闫晓蕾, 李群, 杨勇, 等. 心脏术后体外膜肺氧合支持治疗的医院感染分析[J]. 中华医院感染学杂志, 2011, 21(3): 462-465. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY201103023.htm
|
| [7] |
王静, 熊莹, 施颖, 等. 成人心脏术后患者体外膜肺氧合治疗相关医院感染的危险因素及病原学分析[J]. 中华临床感染病杂志, 2019, 12(1): 38-43. doi: 10.3760/cma.j.issn.1674-2397.2019.01.006
|
| [8] |
AUBRON C, CHENG A C, PILCHER D, et al. Infections acquired by adults who receive extracorporeal membrane oxygenation: risk factors and outcome[J]. Infect Control Hosp Epidemiol, 2013, 34(1): 24-30. doi: 10.1086/668439
|
| [9] |
SCHMIDT M, BRÉCHOT N, HARIRI S, et al. Nosocomial infections in adult cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation[J]. Clin Infect Dis, 2012, 55(12): 1633-1641. doi: 10.1093/cid/cis783
|
| [10] |
KIM G S, LEE K S, PARK C K, et al. Nosocomial infection in adult patients undergoing veno-arterial extracorporeal membrane oxygenation[J]. J Korean Med Sci, 2017, 32(4): 593-598. doi: 10.3346/jkms.2017.32.4.593
|
| [11] |
GRASSELLI G, SCARAVILLI V, DI BELLA S, et al. Nosocomial infections during extracorporeal membrane oxygenation: incidence, etiology, and impact on patients'outcome[J]. Crit Care Med, 2017, 45(10): 1726-1733. doi: 10.1097/CCM.0000000000002652
|
| [12] |
谈宜斌, 王莹, 蔡书翰, 等. 成人体外膜肺氧合术支持治疗患者医院感染流行病学特点[J]. 中华医院感染学杂志, 2020, 30(22): 3434-3438. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY202022017.htm
|
| [13] |
KIM H S, PARK S, KO H H, et al. Different characteristics of bloodstream infection during venoarterial and venovenous extracorporeal membrane oxygenation in adult patients[J]. Sci Rep, 2021, 11(1): 9498. doi: 10.1038/s41598-021-89108-4
|
| [14] |
SUN H Y, KO W J, TSAI P R, et al. Infections occurring during extracorporeal membrane oxygenation use in adult patients[J]. J Thorac Cardiovasc Surg, 2010, 140(5): 1125-1132, e2. doi: 10.1016/j.jtcvs.2010.07.017
|
| [15] |
KUMAR S, SEN P, GAIND R, et al. Prospective surveillance of device-associated health care-associated infection in an intensive care unit of a tertiary care hospital in New Delhi, India[J]. Am J Infect Control, 2018, 46(2): 202-206. doi: 10.1016/j.ajic.2017.08.037
|
| [16] |
CHOUDHURI A H, CHAKRAVARTY M, UPPAL R. Epidemiology and characteristics of nosocomial infections in critically ill patients in a tertiary care Intensive Care Unit of Northern India[J]. Saudi J Anaesth, 2017, 11(4): 402-407. doi: 10.4103/sja.SJA_230_17
|
| [17] |
蔡璇, 施金玲, 李从荣, 等. 重症监护病房病原菌分布及药敏分析[J]. 中国临床药理学杂志, 2021, 37(11): 1403-1407. https://www.cnki.com.cn/Article/CJFDTOTAL-GLYZ202111024.htm
|
| [18] |
MOHD SAZLLY LIM S, SIME F B, ROBERTS J A. Multidrug-resistant Acinetobacter baumannii infections: current evidence on treatment options and the role of pharmacokinetics/pharmacodynamics in dose optimisation[J]. Int J Antimicrob Agents, 2019, 53(6): 726-745. doi: 10.1016/j.ijantimicag.2019.02.016
|
| [19] |
MOHD SAZLLY LIM S, NAICKER S, AYFAN A K, et al. Non-polymyxin-based combinations as potential alternatives in treatment against carbapenem-resistant Acinetobacter baumannii infections[J]. Int J Antimicrob Agents, 2020, 56(4): 106115. doi: 10.1016/j.ijantimicag.2020.106115
|
| [20] |
CANDEL F J, SANTERRE HENRIKSEN A, LONGSHAW C, et al. In vitro activity of the novel siderophore cephalosporin, cefiderocol, in Gram-negative pathogens in Europe by site of infection[J]. Clin Microbiol Infect, 2022, 28(3): 447.e1-447.e6.
|
| [21] |
BIZZARRO M J, CONRAD S A, KAUFMAN D A, et al. Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults[J]. Pediatr Crit Care Med, 2011, 12(3): 277-281. doi: 10.1097/PCC.0b013e3181e28894
|
| [22] |
丁兴芬. ICU医院感染预防与控制的研究[J]. 实用临床医药杂志, 2017, 21(2): 138-139. doi: 10.7619/jcmp.201702045
|
| [23] |
ELLOUZE O, LAMIREL J, PERROT J, et al. Extubation of patients undergoing extracorporeal life support. A retrospective study[J]. Perfusion, 2019, 34(1): 50-57. doi: 10.1177/0267659118791072
|
| [24] |
LI B F, SUN G Q, CHENG Z, et al. Analysis of nosocomial infections in post-cardiac surgery extracorporeal membrane oxygenation support therapy[J]. Heart Surg Forum, 2018, 21(5): E387-E391. doi: 10.1532/hsf.1789
|
| [25] |
MONTERO S, HUANG F, RIVAS-LASARTE M, et al. Awake venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock[J]. Eur Heart J Acute Cardiovasc Care, 2021, 10(6): 585-594. doi: 10.1093/ehjacc/zuab018
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: